Status:
UNKNOWN
Effects on the Qt Interval of COVID-19 Coronavirus Infection
Lead Sponsor:
Matilde Zaballos
Conditions:
Coronavirus Infection
Intensive Care Patients
Eligibility:
All Genders
18+ years
Brief Summary
The present study aims to evaluate the impact of COVID-19 disease and its treatment on ventricular repolarization, assessed by measuring the QTc interval, in patients admitted to the critical care uni...
Detailed Description
Coronavirus infection of Severe Acute Respiratory Syndrome COVID-2 is characterized by a broad clinical spectrum ranging from asymptomatic infection, mild upper respiratory tract disease and severe vi...
Eligibility Criteria
Inclusion
- Patients admitted to intensive care units for COVID-19 infection with an ECG record
Exclusion
- Patients in critical care unit without COVID-19 infection
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04422535
Start Date
May 29 2020
End Date
December 1 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Anestesia, Hospital General Universitario Gregorio Marañon
Madrid, Spain, 28007